Concordia overcharged NHS for thyroid drug, says watchdog

Concordia overcharged NHS for thyroid drug, says watchdog
 

Drug company Concordia overcharged the NHS by millions for a key thyroid treatment, the Competition and Markets Authority has provisionally found.
The CMA said that last year the NHS spent £34m on its drug, liothyronine, up from about £600,000 in 2006.
The amount the NHS paid per pack rose from around £4.46 before it was de-branded in 2007 to £258.19 by July 2017, an increase of almost 6,000%.
Concordia said it did "not believe that competition law has been infringed".
The CMA said the price rise took place despite "broadly stable" production costs.
read more

 
21 November 2017 in Business, Views: 48
Source: BBC
Share:
 




News Widget for Webmasters


Realtime News

 

«
»
Mo Tu We Th Fr Sa Su
        1 2 3
4 5 6 7 8 9 10
11 12 13 14 15 16 17
18 19 20 21 22 23 24
25 26 27 28 29 30 31